Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumatica

Norwegian society of rheumatology recommendations on diagnosis and treatment of patients with giant cell arteritis

(2023) Anne Bull Haaversen et al.   Frontiers in Medicine

Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica

(2023) Christian Dejaco et al.   ANNALS OF THE RHEUMATIC DISEASES

Disease stratification in GCA and PMR: state of the art and future perspectives

(2023) Alessandro Tomelleri et al.   Nature Reviews Rheumatology

Prevalence and characteristics of subclinical giant cell arteritis in polymyalgia rheumatica

(2023) Eugenio De Miguel et al.   RHEUMATOLOGY

EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update

(2023) Christian Dejaco et al.   ANNALS OF THE RHEUMATIC DISEASES

Impact of ultrasound limitation to assess aortitis in patients with giant cell arteritis: comparative study with FDG-PET/CT

(2023) Juan Molina-Collada et al.   RMD Open

Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data

(2022) Andrea K. Hemmig et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis

(2022) Cristina Ponte et al.   ANNALS OF THE RHEUMATIC DISEASES

OMERACT Definition and Reliability Assessment of Chronic Ultrasound Lesions of the Axillary Artery in Giant Cell Arteritis

(2021) Valentin S. Schäfer et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis

(2020) Sarah L Mackie et al.   RHEUMATOLOGY

2018 Update of the EULAR recommendations for the management of large vessel vasculitis

(2019) Bernhard Hellmich et al.   ANNALS OF THE RHEUMATIC DISEASES

Assessing Vasculitis in Giant Cell Arteritis by Ultrasound: Results of OMERACT Patient-based Reliability Exercises

(2018) Valentin S. Schäfer et al.   JOURNAL OF RHEUMATOLOGY

Polymyalgia rheumatica

(2017) Miguel A González-Gay et al.   LANCET

Trial of Tocilizumab in Giant-Cell Arteritis

(2017) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Polymyalgia Rheumatica and Giant Cell Arteritis

(2016) Frank Buttgereit et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease

(2016) Christian Dejaco et al.   RHEUMATOLOGY

2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative

(2015) Christian Dejaco et al.   ANNALS OF THE RHEUMATIC DISEASES

2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative

(2012) Bhaskar Dasgupta et al.   ANNALS OF THE RHEUMATIC DISEASES

Can the prognosis of polymyalgia rheumatica be predicted at disease onset? Results from a 5-year prospective study

(2010) S. L. Mackie et al.   RHEUMATOLOGY

Epidemiology of giant cell arteritis and polymyalgia rheumatica

(2009) Miguel A. Gonzalez-Gay et al.   ARTHRITIS AND RHEUMATISM

Polymyalgia rheumatica and giant-cell arteritis

(2008) Carlo Salvarani et al.   LANCET